N~2~-[(Benzyloxy)carbonyl]-L-arginine(CAS: 1234-35-1)

N~2~-[(Benzyloxy)carbonyl]-L-arginine (CAS: 1234-35-1) falls under the scope of the REACH regulation in the European Union, which requires comprehensive safety data sheets (SDS) and registration for substances above 1 ton per year. In the USA, it is regulated under the Toxic Substances Control Act (TSCA) by the EPA. Additionally, it is classified under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for health and environmental hazards.

Alternative reagents for N~2~-[(Benzyloxy)carbonyl]-L-arginine (CAS: 1234-35-1) include dipeptide building blocks such as N~2~-[(2-chloro-2-methylpropyloxy)carbonyl]-L-arginine or N~2~-[(tert-butoxycarbonyl)-L-arginine. These alternatives can be used in similar chemical reactions, providing flexibility in synthetic routes.

The market for N~2~-[(Benzyloxy)carbonyl]-L-arginine (CAS: 1234-35-1) is growing due to its applications in pharmaceuticals and as a precursor in peptide synthesis. Research is focusing on its use in drug discovery and development, particularly in the treatment of cardiovascular diseases and inflammation. Market trends indicate increasing demand for this compound as its therapeutic potential is explored further.

Waste containing N~2~-[(Benzyloxy)carbonyl]-L-arginine (CAS: 1234-35-1) should be collected in appropriate containers and stored in a well-ventilated area. It should be disposed of through professional waste disposal services that follow the regulations set by the EPA and OSHA. Environmental protection measures include proper containment to prevent leakage and precautionary measures to avoid skin and eye contact during handling.